PHARMEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMEDIC
Largest movements
- Stocks and contracts +€46,861
up €46,861 (+28.7%), from €163,384 to €210,245
- Cash -€43,365
down €43,365 (-43.2%), from €100,486 to €57,121
mainly Debts after one year (-€69,387) and Stocks and contracts (-€46,861)
- Receivables within one year +€33,076
up €33,076 (+61.1%), from €54,167 to €87,242
of which Trade receivables: +€26,634
- Tangible fixed assets -€22,262
down €22,262 (-2.8%), from €806,591 to €784,329
of which Furniture and vehicles: -€18,031
- Intangible fixed assets -€19,161
down €19,161 (-11.8%), from €162,661 to €143,500
- Debts after one year -€69,387
down €69,387 (-8.0%), from €872,395 to €803,008
- Reserves +€54,336
up €54,336 (+201.8%), from €26,920 to €81,256
of which Distributable reserves: +€54,336
- Trade debts +€26,979
up €26,979 (+131.2%), from €20,557 to €47,536
- Other debts -€16,503
down €16,503 (-7.0%), from €234,465 to €217,962
- Gross operating margin +€61,505
up €61,505 (+37.9%), from €162,418 to €223,924
- Taxes +€11,297
up €11,297 (+604.1%), from €1,870 to €13,167
- Financial charges +€5,284
up €5,284 (+14.5%), from €36,497 to €41,781
- Staff costs +€4,847
up €4,847 (+16.6%), from €29,163 to €34,009
- Depreciation +€4,770
up €4,770 (+6.4%), from €74,208 to €78,978
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,288,955 | €1,284,697 | -€4,258 | -0.3% |
| Fixed assets | 21/28 | €969,253 | €927,829 | -€41,424 | -4.3% |
| Intangible fixed assets | 21 | €162,661 | €143,500 | -€19,161 | -11.8% |
| Tangible fixed assets | 22/27 | €806,591 | €784,329 | -€22,262 | -2.8% |
| Land and buildings | 22 | €702,345 | €709,016 | +€6,671 | +0.9% |
| Plant, machinery and equipment | 23 | €45,040 | €34,137 | -€10,902 | -24.2% |
| Furniture and vehicles | 24 | €59,207 | €41,176 | -€18,031 | -30.5% |
| Current assets | 29/58 | €319,702 | €356,868 | +€37,166 | +11.6% |
| Stocks and contracts in progress | 3 | €163,384 | €210,245 | +€46,861 | +28.7% |
| Stocks | 30/36 | €163,384 | €210,245 | +€46,861 | +28.7% |
| Amounts receivable within one year | 40/41 | €54,167 | €87,242 | +€33,076 | +61.1% |
| Trade receivables | 40 | €35,646 | €62,279 | +€26,634 | +74.7% |
| Other amounts receivable | 41 | €18,521 | €24,963 | +€6,442 | +34.8% |
| Cash at bank and in hand | 54/58 | €100,486 | €57,121 | -€43,365 | -43.2% |
| Deferred charges and accrued income | 490/1 | €1,666 | €2,261 | +€595 | +35.7% |
| Total equity and liabilities | 10/49 | €1,288,955 | €1,284,697 | -€4,258 | -0.3% |
| Equity | 10/15 | €75,585 | €129,921 | +€54,336 | +71.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €26,920 | €81,256 | +€54,336 | +201.8% |
| Non-distributable reserves | 130/1 | €720 | €720 | = | 0.0% |
| Reserves not available under the articles | 1311 | €720 | €720 | = | 0.0% |
| Distributable reserves | 133 | €26,200 | €80,536 | +€54,336 | +207.4% |
| Profit (loss) carried forward | 14 | €30,065 | €30,065 | = | 0.0% |
| Amounts payable | 17/49 | €1,213,370 | €1,154,776 | -€58,594 | -4.8% |
| Amounts payable after more than one year | 17 | €872,395 | €803,008 | -€69,387 | -8.0% |
| Financial debts | 170/4 | €872,395 | €803,008 | -€69,387 | -8.0% |
| Amounts payable within one year | 42/48 | €340,975 | €351,768 | +€10,793 | +3.2% |
| Current portion of amounts payable after more than one year | 42 | €74,436 | €70,429 | -€4,007 | -5.4% |
| Financial debts | 43 | €6,757 | €6,732 | -€25 | -0.4% |
| Credit institutions | 430/8 | €6,757 | €6,732 | -€25 | -0.4% |
| Trade debts | 44 | €20,557 | €47,536 | +€26,979 | +131.2% |
| Suppliers | 440/4 | €20,557 | €47,536 | +€26,979 | +131.2% |
| Taxes, remuneration and social security | 45 | €4,761 | €9,109 | +€4,349 | +91.3% |
| Taxes | 450/3 | €2,006 | €3,682 | +€1,676 | +83.5% |
| Remuneration and social security | 454/9 | €2,754 | €5,427 | +€2,673 | +97.1% |
| Other amounts payable | 47/48 | €234,465 | €217,962 | -€16,503 | -7.0% |
| Remuneration, social security and pensions | 62 | €29,163 | €34,009 | +€4,847 | +16.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €74,208 | €78,978 | +€4,770 | +6.4% |
| Other operating charges | 640/8 | €1,904 | €1,733 | -€171 | -9.0% |
| Gross operating margin | 9900 | €162,418 | €223,924 | +€61,505 | +37.9% |
| Operating profit (loss) | 9901 | €57,144 | €109,203 | +€52,060 | +91.1% |
| Financial income | 75/76B | - | €81 | +€81 | |
| Recurring financial income | 75 | - | €81 | +€81 | |
| Financial charges | 65/66B | €36,497 | €41,781 | +€5,284 | +14.5% |
| Recurring financial charges | 65 | €36,497 | €41,781 | +€5,284 | +14.5% |
| Profit (loss) for the period before taxes | 9903 | €20,647 | €67,503 | +€46,857 | +226.9% |
| Income taxes | 67/77 | €1,870 | €13,167 | +€11,297 | +604.1% |
| Profit (loss) for the period | 9904 | €18,777 | €54,336 | +€35,560 | +189.4% |
| Profit (loss) for the period to be appropriated | 9905 | €18,777 | €54,336 | +€35,560 | +189.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.